Treatment of Vasogenic Edema

Pathogenesis:  production of VEGF, glutamate, leukotrienes (increases permeability of tumor vessels) and absence of tight endothelial cell junctions in tumor blood vessels (respond to VEGF and basic fibroblast growth factor)
Gliomas, meningiomas, metastatic tumors –> secretes VEGF –> binds to VEGFR1 and VEGFR2 (surface of endothelial cells –> formation of gaps in endothelium –> fluid leakage into brain parenchyma –> vasogenic edema –> spreads more in white matter (lower resistance than gray matter) –>  disrupts synaptic transmission, alters neuronal excitability –> HA, seizures, focal deficits, encephalopathy, herniation
Advantages:  Lack of mineralocorticoid activity, less fluid retention; lower risk of infection and cognitive impairment
Mechanism:  Upregulates Ang-1 (BBB-stabilizing factor) and downregulates VEGF in astrocytes and pericytes; increases clearance of peritumoral edema by facilitating transport of fluid into ventricular system
  • Severe symptoms: 10mg IV loading dose then 4mg QID or 8 mg BID
  • Lower doses (1-2mg QID) may be as effective and less toxic
  • Long half life allows BID dosing
  • Improves within hours, maximum benefit within 24-72 hours, neuroimaging may not confirm until at least 1 week
  • If 16mg/day insufficient, may increase up to 100mg/day
  • Taper:  once improved, taper by 50% every 4 days
  • severe symptoms:  16mg/d or more
  • milder symptoms: start 4-8mg daily
  • asymptomatic: steroids not recommended
  • taper over 2 week period or longer
  • Insomnia, essential tremor, hiccups
  • GI complications
  • Steroid myopathy – prox weakness in week 9-12
  • PCP infection – risk increases while tapering steroids; fever and dyspnea and dry cough but can be subtle and nonspecific
Novel treatments:
  1. bevacizumab (anti-VEGF monoclonal antibodies)
  2. corticotrophin-releasing factor
  3. COX-2 inhibitors?




Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s